156 related articles for article (PubMed ID: 25413730)
1. Grouping of nanomaterials for risk assessment.
Bolt HM
Arch Toxicol; 2014 Dec; 88(12):2077-8. PubMed ID: 25413730
[No Abstract] [Full Text] [Related]
2. Manufactured nanomaterials: categorization and approaches to hazard assessment.
Gebel T; Foth H; Damm G; Freyberger A; Kramer PJ; Lilienblum W; Röhl C; Schupp T; Weiss C; Wollin KM; Hengstler JG
Arch Toxicol; 2014 Dec; 88(12):2191-211. PubMed ID: 25326817
[TBL] [Abstract][Full Text] [Related]
3. Pluripotent stem cells: An in vitro model for nanotoxicity assessments.
Handral HK; Tong HJ; Islam I; Sriram G; Rosa V; Cao T
J Appl Toxicol; 2016 Oct; 36(10):1250-8. PubMed ID: 27241574
[TBL] [Abstract][Full Text] [Related]
4. Application of Bayesian networks for hazard ranking of nanomaterials to support human health risk assessment.
Marvin HJ; Bouzembrak Y; Janssen EM; van der Zande M; Murphy F; Sheehan B; Mullins M; Bouwmeester H
Nanotoxicology; 2017 Feb; 11(1):123-133. PubMed ID: 28044458
[TBL] [Abstract][Full Text] [Related]
5. Grouping of nanomaterials to read-across hazard endpoints: from data collection to assessment of the grouping hypothesis by application of chemoinformatic techniques.
Lamon L; Asturiol D; Richarz A; Joossens E; Graepel R; Aschberger K; Worth A
Part Fibre Toxicol; 2018 Sep; 15(1):37. PubMed ID: 30249272
[TBL] [Abstract][Full Text] [Related]
6. Grouping of nanomaterials to read-across hazard endpoints: a review.
Lamon L; Aschberger K; Asturiol D; Richarz A; Worth A
Nanotoxicology; 2019 Feb; 13(1):100-118. PubMed ID: 30182776
[TBL] [Abstract][Full Text] [Related]
7. [Safety of medicinal nanoproducts: new areas of toxicological research].
Grudziński IP
Rocz Panstw Zakl Hig; 2011; 62(3):239-46. PubMed ID: 22171512
[TBL] [Abstract][Full Text] [Related]
8. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.
Holsapple MP; Farland WH; Landry TD; Monteiro-Riviere NA; Carter JM; Walker NJ; Thomas KV
Toxicol Sci; 2005 Nov; 88(1):12-7. PubMed ID: 16120754
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity screening and cytokine profiling of nineteen nanomaterials enables hazard ranking and grouping based on inflammogenic potential.
Bhattacharya K; Kiliç G; Costa PM; Fadeel B
Nanotoxicology; 2017 Aug; 11(6):809-826. PubMed ID: 28816564
[TBL] [Abstract][Full Text] [Related]
10. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices.
Bouwmeester H; Lynch I; Marvin HJ; Dawson KA; Berges M; Braguer D; Byrne HJ; Casey A; Chambers G; Clift MJ; Elia G; Fernandes TF; Fjellsbø LB; Hatto P; Juillerat L; Klein C; Kreyling WG; Nickel C; Riediker M; Stone V
Nanotoxicology; 2011 Mar; 5(1):1-11. PubMed ID: 21417684
[TBL] [Abstract][Full Text] [Related]
11. Nanomaterial health effects--part 1: background and current knowledge.
Powell MC; Kanarek MS
WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
[TBL] [Abstract][Full Text] [Related]
12. Toxicity assessment of nanomaterials: methods and challenges.
Dhawan A; Sharma V
Anal Bioanal Chem; 2010 Sep; 398(2):589-605. PubMed ID: 20652549
[TBL] [Abstract][Full Text] [Related]
13. Reproductive Toxicology. Editorial.
Piersma AH
Reprod Toxicol; 2010 Aug; 30(1):1. PubMed ID: 20580665
[No Abstract] [Full Text] [Related]
14. The changing face of nanomaterials: Risk assessment challenges along the value chain.
Mattsson MO; Simkó M
Regul Toxicol Pharmacol; 2017 Mar; 84():105-115. PubMed ID: 27998719
[TBL] [Abstract][Full Text] [Related]
15. Immunotoxicity: hazard identification and risk assessment.
Luster MI; Kimber I
Hum Exp Toxicol; 1996 Dec; 15(12):947-8. PubMed ID: 8981097
[No Abstract] [Full Text] [Related]
16. The applicability of chemical alternatives assessment for engineered nanomaterials.
Hjorth R; Hansen SF; Jacobs M; Tickner J; Ellenbecker M; Baun A
Integr Environ Assess Manag; 2017 Jan; 13(1):177-187. PubMed ID: 26887668
[TBL] [Abstract][Full Text] [Related]
17. Uncertainty factors in noncancer risk assessment.
Dourson M
Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):107. PubMed ID: 8933623
[No Abstract] [Full Text] [Related]
18. TOXNET: information on toxicology and environmental health.
Fowler S; Schnall JG
Am J Nurs; 2014 Feb; 114(2):61-3. PubMed ID: 24481372
[No Abstract] [Full Text] [Related]
19. Nanomaterial health effects part 3: conclusion--hazardous issues and the precautionary principle.
Kanarek MS
WMJ; 2007 Feb; 106(1):16-9. PubMed ID: 17393752
[TBL] [Abstract][Full Text] [Related]
20. Nanomaterial health effects--Part 2: Uncertainties and recommendations for the future.
Powell MC; Kanarek MS
WMJ; 2006 May; 105(3):18-23. PubMed ID: 16749320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
